Rare side effects of Mounjaro: what they are and when to act

What does 'rare' actually mean in the context of Mounjaro's side-effect profile?

When regulators classify a side effect as rare, they mean it affects fewer than one person in a thousand taking the medicine, not that it has never happened. Common effects on Mounjaro, such as nausea, indigestion and loose stools, are well-documented on the NHS tirzepatide medicines page. Rare effects sit in a different category: they are less predictable, less researched in everyday clinical use, and sometimes more serious when they do occur.

Understanding that distinction matters for one practical reason: common side effects usually peak in the first few days after a dose and then settle. Rare effects don't follow that tidy pattern. They can appear at any point in treatment, which is why knowing the warning signs in advance is more useful than waiting to see how you feel.

The full list of recognised effects (common and rare) is set out in the Mounjaro Summary of Product Characteristics on the Electronic Medicines Compendium (eMC), which is the authoritative reference for prescribers and patients alike. If you are already on Mounjaro, your Patient Information Leaflet, which comes inside every pack, is the most direct source for the complete, dose-specific list, and our Mounjaro treatment page also gives a useful overview of how the medicine works before you reach for the leaflet. The sections below focus on the rare effects most worth understanding.

Which rare Mounjaro side effects have regulators specifically flagged?

Acute pancreatitis is the one that attracts most clinical attention. On 29 January 2026, the MHRA published a formal Drug Safety Update for GLP-1 medicines (which includes tirzepatide) highlighting pancreatitis as an infrequent but potentially serious risk. The symptom to know is severe, persistent stomach pain that may spread towards the back, sometimes accompanied by vomiting. This is different from the ordinary bloating or reflux that many people experience in the early weeks. Pancreatic pain tends to be more intense, doesn't pass quickly, and is not relieved by changing position. If it fits that description, seek urgent medical help.

Gallbladder disease (including gallstones and gallbladder inflammation) has also been reported. Weight loss itself, including the rapid kind, increases bile concentration, which raises the risk of stone formation. Upper-right abdominal pain, particularly after eating fatty food, yellowing of the skin or eyes, or dark urine, are the relevant signals.

Kidney-related problems are a rarer consequence of severe dehydration, which can follow significant vomiting or diarrhoea. On its own, this is not a direct drug effect, but it is a reminder that staying hydrated matters, especially in the first weeks when GI symptoms are most likely. Our broader overview of Mounjaro side effects covers the dehydration risk in more detail.

When should someone get medical help, and how urgently?

Some situations are emergencies. Call 999 or go to A&E immediately for: severe allergic reactions (swelling of the face, lips, tongue or throat; difficulty swallowing or breathing; sudden rash with dizziness); severe chest pain; or any sign of a serious allergic response shortly after an injection.

Contact your GP or 111 the same day (do not wait for your next review) for: severe stomach pain that reaches the back and does not settle within an hour or two; upper-right abdominal pain or jaundice; significant reduction in urination after a bout of vomiting or diarrhoea; or any new or worsening vision changes if you have type 2 diabetes alongside Mounjaro.

Changes in mood, low mood, or thoughts of self-harm are listed among effects to monitor in the trial programme. It is also worth knowing that people sometimes search for information about a specific side effect of Mounjaro they have noticed, which can be a sensible first step before contacting a prescriber. If you or someone close to you notices a meaningful shift in mental state after starting treatment, raise it with your prescriber without delay. You can reach us through our support team seven days a week if you need to flag something outside a scheduled review.

For a closer look at how specific doses relate to tolerability, the 5mg side effects page goes into that in more detail.

How do you report a suspected side effect, and why does it matter?

The MHRA's Yellow Card scheme lets anyone (patients, carers, prescribers) report a suspected adverse reaction. You do not need to be certain that the medicine caused it; suspicion is enough. Reporting at yellowcard.mhra.gov.uk feeds directly into the national pharmacovigilance system that updates guidance like the January 2026 Drug Safety Update above.

Mounjaro still carries a Black Triangle (▼) designation, which means regulators actively encourage reporting of any suspected reaction, however minor it seems. If you want a thorough picture of what the side effects of Mounjaro are before you decide whether something is worth reporting, that dedicated page sets out the recognised reactions clearly. The pen you keep on the fridge shelf at home (and any effect you notice after using it) is part of that ongoing safety picture for everyone on treatment.

At nume, our prescribers talk through both common and rare side effects during the consultation, and every repeat order receives a clinical review before it is approved. It is also reassuring to know that some people find they experience no side effects on Mounjaro at all, though everyone's response to the medicine is individual. If you are thinking about starting treatment, our free consultation is the right first step. Our clinical team can answer questions about your specific history, medications and risk factors.